153 related articles for article (PubMed ID: 23538188)
21. Identification of undiagnosed atrial fibrillation using a machine learning risk prediction algorithm and diagnostic testing (PULsE-AI) in primary care: cost-effectiveness of a screening strategy evaluated in a randomized controlled trial in England.
Hill NR; Groves L; Dickerson C; Boyce R; Lawton S; Hurst M; Pollock KG; Sugrue DM; Lister S; Arden C; Davies DW; Martin AC; Sandler B; Gordon J; Farooqui U; Clifton D; Mallen C; Rogers J; Camm AJ; Cohen AT
J Med Econ; 2022; 25(1):974-983. PubMed ID: 35834373
[TBL] [Abstract][Full Text] [Related]
22. Long-term cost-effectiveness of collaborative care (vs usual care) for people with depression and comorbid diabetes or cardiovascular disease: a Markov model informed by the COINCIDE randomised controlled trial.
Camacho EM; Ntais D; Coventry P; Bower P; Lovell K; Chew-Graham C; Baguley C; Gask L; Dickens C; Davies LM
BMJ Open; 2016 Oct; 6(10):e012514. PubMed ID: 27855101
[TBL] [Abstract][Full Text] [Related]
23. Dermoscopy for the diagnosis of melanoma: primary care diagnostic technology update.
Plüddemann A; Heneghan C; Thompson M; Wolstenholme J; Price CP
Br J Gen Pract; 2011 Jun; 61(587):416-7. PubMed ID: 21801535
[No Abstract] [Full Text] [Related]
24. Short-term and long-term cost-effectiveness of a pedometer-based exercise intervention in primary care: a within-trial analysis and beyond-trial modelling.
Anokye N; Fox-Rushby J; Sanghera S; Cook DG; Limb E; Furness C; Kerry SM; Victor CR; Iliffe S; Ussher M; Whincup PH; Ekelund U; deWilde S; Harris T
BMJ Open; 2018 Oct; 8(10):e021978. PubMed ID: 30337309
[TBL] [Abstract][Full Text] [Related]
25. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.
Saborido CM; Hockenhull J; Bagust A; Boland A; Dickson R; Todd D
Health Technol Assess; 2010 Jun; 14(31):iii-iv, 1-75. PubMed ID: 20569652
[TBL] [Abstract][Full Text] [Related]
26. The cost-effectiveness of screening for oral cancer in primary care.
Speight PM; Palmer S; Moles DR; Downer MC; Smith DH; Henriksson M; Augustovski F
Health Technol Assess; 2006 Apr; 10(14):1-144, iii-iv. PubMed ID: 16707071
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness of a FISH assay for the diagnosis of melanoma in the USA.
Kansal AR; Shaul AJ; Stern S; Busam K; Doucet CA; Chalfin DB
Expert Rev Pharmacoecon Outcomes Res; 2013 Jun; 13(3):371-80. PubMed ID: 23672374
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness of screening for atrial fibrillation in primary care with a handheld, single-lead electrocardiogram device in the Netherlands.
Jacobs MS; Kaasenbrood F; Postma MJ; van Hulst M; Tieleman RG
Europace; 2018 Jan; 20(1):12-18. PubMed ID: 27733465
[TBL] [Abstract][Full Text] [Related]
29. Internet-based skin cancer screening using clinical images alone or in conjunction with dermoscopic images: A randomized teledermoscopy trial.
Ferrándiz L; Ojeda-Vila T; Corrales A; Martín-Gutiérrez FJ; Ruíz-de-Casas A; Galdeano R; Álvarez-Torralba I; Sánchez-Ibáñez F; Domínguez-Toro JM; Encina F; Narbona FJ; Herrerías-Esteban JM; Moreno-Ramírez D
J Am Acad Dermatol; 2017 Apr; 76(4):676-682. PubMed ID: 28089728
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness analysis in melanoma detection: A transition model applied to dermoscopy.
Tromme I; Legrand C; Devleesschauwer B; Leiter U; Suciu S; Eggermont A; Sacré L; Baurain JF; Thomas L; Beutels P; Speybroeck N
Eur J Cancer; 2016 Nov; 67():38-45. PubMed ID: 27592070
[TBL] [Abstract][Full Text] [Related]
31. Modelling the cost-effectiveness of sentinel lymph node mapping and adjuvant interferon treatment for stage II melanoma.
Wilson LS; Reyes CM; Lu C; Lu M; Yen C
Melanoma Res; 2002 Dec; 12(6):607-17. PubMed ID: 12459651
[TBL] [Abstract][Full Text] [Related]
32. Cost-Effectiveness and Value of Information of Erlotinib, Afatinib, and Cisplatin-Pemetrexed for First-Line Treatment of Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer in the United States.
Ting J; Tien Ho P; Xiang P; Sugay A; Abdel-Sattar M; Wilson L
Value Health; 2015 Sep; 18(6):774-82. PubMed ID: 26409604
[TBL] [Abstract][Full Text] [Related]
33. Elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia: a systematic review and economic evaluation.
Sharma P; Boyers D; Boachie C; Stewart F; Miedzybrodzka Z; Simpson W; Kilonzo M; McNamee P; Mowatt G
Health Technol Assess; 2012; 16(17):1-266. PubMed ID: 22469073
[TBL] [Abstract][Full Text] [Related]
34. Modelling the cost effectiveness of antidepressant treatment in primary care.
Revicki DA; Brown RE; Palmer W; Bakish D; Rosser WW; Anton SF; Feeny D
Pharmacoeconomics; 1995 Dec; 8(6):524-40. PubMed ID: 10160081
[TBL] [Abstract][Full Text] [Related]
35. The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk.
Fairbairn TA; Meads DM; Hulme C; Mather AN; Plein S; Blackman DJ; Greenwood JP
Heart; 2013 Jul; 99(13):914-20. PubMed ID: 23696198
[TBL] [Abstract][Full Text] [Related]
36. Cohort versus patient level simulation for the economic evaluation of single versus combination immuno-oncology therapies in metastatic melanoma.
Gibson EJ; Begum N; Koblbauer I; Dranitsaris G; Liew D; McEwan P; Yuan Y; Juarez-Garcia A; Tyas D; Pritchard C
J Med Econ; 2019 Jun; 22(6):531-544. PubMed ID: 30638416
[No Abstract] [Full Text] [Related]
37. Laparoscopic supracervical hysterectomy compared with second-generation endometrial ablation for heavy menstrual bleeding: the HEALTH RCT.
Cooper K; Breeman S; Scott NW; Scotland G; Hernández R; Clark TJ; Hawe J; Hawthorn R; Phillips K; Wileman S; McCormack K; Norrie J; Bhattacharya S
Health Technol Assess; 2019 Sep; 23(53):1-108. PubMed ID: 31577219
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic accuracy and cost-effectiveness of dermoscopy in primary care: a cluster randomized clinical trial.
Koelink CJ; Vermeulen KM; Kollen BJ; de Bock GH; Dekker JH; Jonkman MF; van der Heide WK
J Eur Acad Dermatol Venereol; 2014 Nov; 28(11):1442-9. PubMed ID: 25493316
[TBL] [Abstract][Full Text] [Related]
39. Growth monitoring for short stature: update of a systematic review and economic model.
Craig D; Fayter D; Stirk L; Crott R
Health Technol Assess; 2011 Feb; 15(11):iii-iv, 1-64. PubMed ID: 21356163
[TBL] [Abstract][Full Text] [Related]
40. The cost-effectiveness of testing for hepatitis C in former injecting drug users.
Castelnuovo E; Thompson-Coon J; Pitt M; Cramp M; Siebert U; Price A; Stein K
Health Technol Assess; 2006 Sep; 10(32):iii-iv, ix-xii, 1-93. PubMed ID: 16948891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
